Answers are grounded in this paper and cite their sources.
Reports short-term eplerenone use for hypertension and hypokalemia in pregnant women with primary aldosteronism, highlighting a potential medical strategy.
Primary aldosteronism (PA) in pregnancy is rare. Due to pharmacological limitations and risks associated with surgical intervention during pregnancy, clinical decision making in this area is difficult. We report the short-term use of eplerenone in the management of hypertension and hypokalemia due to PA in pregnancy.
No takes yet. Share an insight, caveat, or question.
Gunganah et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: